• Work With Us
    • Partnerships
      • We offer tailored partnerships to support and transform drug discovery.

        Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

    • Services
      • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

        As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

    • OrganoReady®
      • Our OrganoReady program is made for you when you need defined assays in ADME.

        We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Resources & Support
    • Knowledge Center
      • Get inspired by peer-reviewed publications, webinars, whitepapers, app notes and more in our knowledge center.

    • Blogs
      • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
    • Case Studies
      • Get inspired by research done by our scientists, partners, and customers around the globe.

    • Webinars & Events
    • Applications
  • About MIMETAS
  • News
  • We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need defined assays in ADME.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Get inspired by peer-reviewed publications, webinars, whitepapers, app notes and more in our knowledge center.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

MIMETAS partner in €4.5mn EU Interreg project BIOMAT

Engineering 3D microenvironments of vascularized bone and muscle

January 1, 2018 – The objective of the 'Biomat' project is to develop a platform for high-throughput testing of biomaterials in a physiologically relevant environment on-a-chip. The innovative aspects of this platform are a 3D environment that mimics relevant tissues in which novel and existing biomaterials can be integrated for reliable in vitro testing and monitoring.

Bones- and Muscles-on-a-Chip

Within this project, 3D microenvironments of vascularized bone and muscle will be engineered on microfluidic chips and used to test the performance of biomaterials, such as hip implants, bone fillers, and stents. MIMETAS' OrganoPlate® technology offers unique functionalities, not possible with conventional 2D or 3D culture, allowing to better replicate the complex microenvironment of bones and muscles. In addition, MIMETAS' perfused vascular beds, that recapitulate hallmark features of human microvessels, will play an important role in the project.

Within the first two years of the Biomat-on-Microfluidic Chip project, important steps towards creating a new generation of patient-specific organ-on-chip platforms were taken by developing several engineering and biological technologies.

  • First designs and models of the chip have been made in the form of inserts for culture plates. We have succeeded in forming three-dimensional biological micro-constructs of patient-specific cells and various biomaterials at a micron scale. In addition to that, we have developed multiple robust bioassays for screening the toxicity/biocompatibility and the functionality of newly developed biomaterials;
  • Although this 3D model has been tested with human cell lines and stem cells, we have also optimized protocols for differentiating human-induced pluripotent stem cells (hiPSCs) towards muscle and bone tissues and for coupling these cells with reporters with which their growth and metabolism can be monitored non-invasively. Furthermore, we have shown the formation of 3D micro-tissues using these cells;
  • The development of the platform for vascularization of 3D micro-tissues has also been demonstrated;
  • In addition to that, we have developed a sensor that can be coupled to the chip in order to monitor tissue formation overtime;
  • We have developed a technology for the fabrication of micro-biomaterials with different chemistries that can be screened in the platform for biocompatibility and biological functionality.

Partners and Funding

Other partners in the project are: Universiteit Maastricht - MERLN Institute for Technology-Inspired Regenerative Medicine (NL), Katholieke Universiteit Leuven (BE), Xplore Instruments B.V. (NL), Leids Universitair Medisch Centrum (NL), Tenco DDM (BE), DSM R&D Solutions B.V. (NL) and Interuniversitair Micro-Elektronica Centrum - IMEC (BE).

The project was awarded an Interreg Flanders-The Netherlands grant, support from the Dutch Department of Economic Affairs and the Province of Zuid-Holland on a total project budget of €4.5mn.


Sign up for our Newsletter

Cookies

‘May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy

Accept all
Accept selected
Decline all